1. Expression of cyclin D1, p21WAF1, p53 and Ki-67 in hepatocellular carcinoma: a pathological study
- Author
-
Yu-lan WANG, Jing-li DU, Huai-yin SHI, Ai-tao GUO, Li-xin WEI, and Jing-min ZHAO
- Subjects
lcsh:R5-920 ,cyclin-dependent kinase inhibitor p21 ,tumor suppressor protein p53 ,lcsh:R ,cyclin D1 ,lcsh:Medicine ,Ki-67 antigen ,lcsh:Medicine (General) ,carcinoma, hepatocellular - Abstract
Objective To explore the expression of cyclin D1, p21WAF1, p53 and Ki-67 protein in hepatocellular carcinoma (HCC) and its relationship with prognosis of HCC patients. Methods Liver specimens were collected from 80 HCC patients who received hepatectomy in the General Hospital of PLA from Jan. 2000 to Jan. 2005, and the expressions of cyclin D1, p21WAF1, p53 and Ki-67 protein were determined by immunohistochemical staining (EliVision method) to investigate the relationship between the protein expressions and the clinicopathologic characteristics of HCC, and their relationship with the survival rate of the patients was analyzed. Results The positive expression rates of cyclin D1, p21WAF1, p53 and Ki-67 in HCC were 38.8%, 40.5%, 65.4% and 80.0% respectively, and they were significantly higher than those in matched normal tissues (19.0%, 11.5%, 0.0% and 6.3% respectively, P
- Published
- 2014